Hims & Hers: Growth Catalysts Or Margin Trap

Hims & Hers was rated Hold amid margin pressure, Amazon-driven competition, & uncertain catalysts. Learn more about HIMS ...
Nasdaq

Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers

The acquisition will unlock a new level of personalized healthcare and deliver integrated offerings across nutrition, lifestyle, supplements, and medication SAN FRANCISCO--(BUSINESS WIRE)-- Hims & ...

Hims & Hers Health: Could Start To Look Interesting In 2026

Hims & Hers Health, Inc. analysis: subscription health platform growth, GLP-1 risks, and catalysts in women’s health & ...
NBC New York

Hims & Hers to offer at-home blood draws, lean into ‘peptide innovations' with new acquisitions

The deal will allow the telehealth company to offer at-home blood draws and more comprehensive pretreatment testing to its users. "Access to richer data allows us to deepen the insights that providers ...
Wall Street Journal

Hims & Hers Bets on Lab Testing to Boost Growth

Hims & Hers Health HIMS2.89%increase; green up pointing triangle is offering lab testing, part of the telehealth platform’s growing focus on preventive care. The company expects the new offering to ...
Benzinga.com

Hims & Hers Health Stock Hits All-Time Highs: What's Going On?

Hims & Hers Health Inc (NYSE:HIMS) shares are soaring Wednesday after the company announced plans to introduce at-home lab testing. Positive analyst coverage may also be boosting the stock. Here’s ...
NBC 7 San Diego

Hims & Hers to offer at-home blood draws, lean into ‘peptide innovations' with new acquisitions

Hims & Hers Health announced Wednesday it has acquired New Jersey-based at-home lab testing facility Trybe Labs. The deal will allow the telehealth company to offer at-home blood draws and more ...